Kondor Pharma Inc, is developing and commercializing evidenced-based nutraceuticals for treatment or management of symptoms of neurological disorders. Kondor's current products include three clinically-proven products, Memowell, Strowell, and Genuwell to manage aging-associated conditions caused by chronic inflammation. Kondor Pharma’s headquarter/ R&D facility is located in Mississauga, Canada.
Company Details
- Employees
- 8
- Founded
- 2018
- Address
- 3403 American Dr, Mississauga,ontario L4v 1t4,canada
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- inflawell.com
- Keywords
- Waterloo.
- HQ
- Mississauga, Ontario
Kondor Pharma Inc. Questions
Kondor Pharma Inc.'s website is inflawell.com
Kondor Pharma Inc.'s LinkedIn profile is https://ca.linkedin.com/company/kondor-pharma-inc
Kondor Pharma Inc. has
8 employees.
View email and phone details for 8
employees at Kondor Pharma Inc..
Kondor Pharma Inc.'s industry is
Pharmaceutical Manufacturing
Kondor Pharma Inc.'s top competitors are
Dr. Mojallali Pharmaceutical Chemical Industries Complex Co.,
Clear Spider Inventory Management Solutions,
Waterloo Data & Artificial Intelligence Institute,
Royal Pharma,
Ion Pharma Usa,
Avin Darou Salamat,
Marcan Pharmaceuticals Inc.,
Kondor Pharma Iran,
Nutrasen Pharma,
Famlinet.
Kondor Pharma Inc.'s categories are Pharmaceutical Manufacturing
Kondor Pharma Inc.'s founding year is 2018
